Total planned funding: $1,397,282,006
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Tanzania | $237,471,525 |
Zambia | $189,988,499 |
Nigeria | $185,926,177 |
Mozambique | $97,275,759 |
Uganda | $97,139,132 |
Kenya | $90,485,870 |
South Africa | $79,559,896 |
Ethiopia | $65,476,002 |
Zimbabwe | $64,308,680 |
Haiti | $54,461,584 |
Côte d'Ivoire | $46,932,290 |
Rwanda | $44,624,897 |
Namibia | $29,291,238 |
Eswatini | $24,568,989 |
Democratic Republic of the Congo | $17,886,742 |
Botswana | $15,151,835 |
Malawi | $12,617,780 |
Burundi | $5,834,057 |
Indonesia | $4,972,565 |
Ghana | $4,831,291 |
Lesotho | $3,884,432 |
Cameroon | $3,558,624 |
Ukraine | $3,402,913 |
Vietnam | $2,970,581 |
Guyana | $2,470,000 |
South Sudan | $2,288,839 |
Central Asia Region | $2,232,129 |
Dominican Republic | $2,068,236 |
Central America Region | $1,271,444 |
Caribbean Region | $1,160,000 |
Cambodia | $1,150,000 |
Russia | $770,000 |
India | $750,000 |
Angola | $500,000 |
Organizational Types
Private Contractor | $1,397,282,006 |
Program Areas
Treatment | $833,735,442 |
Care | $199,242,868 |
Governance and Systems | $164,791,466 |
Prevention | $149,459,516 |
Testing | $48,341,755 |
Budget Codes
HTXD: Treatment: ARV Drugs | $602,768,418 |
HTXS: Treatment: Adult Treatment | $213,629,033 |
OHSS: Health Systems Strengthening | $96,043,062 |
HBHC: Care: Adult Care and Support | $85,347,127 |
HKID: Care: Orphans and Vulnerable Children | $68,659,925 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $48,894,308 |
HVCT: Testing: HIV Testing and Counseling | $48,341,755 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $44,849,951 |
HLAB: Laboratory Infrastructure | $37,794,411 |
HVSI: Strategic Information | $30,953,993 |
HVTB: Care: TB/HIV | $27,508,215 |
HVOP: Sexual Prevention: Other Sexual Prevention | $26,791,009 |
PDCS: Care: Pediatric Care and Support | $17,727,601 |
PDTX: Treatment: Pediatric Treatment | $17,337,991 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $16,085,064 |
HMIN: Biomedical Prevention: Injection Safety | $8,527,177 |
HMBL: Biomedical Prevention: Blood Safety | $2,565,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,747,007 |
Top Partner Programs
Chemonics International:
$641,153,156
View countries